The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis-Reference-Cited by-同舟云学术

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis

Published:2020-07-03 Issue:1 Volume:27 Page:
ISSN:1423-0127
Container-title:Journal of Biomedical Science
language:en
Short-container-title:J Biomed Sci

Author:

Wang Ying-Nai,Lee Heng-Huan,Hsu Jennifer L.,Yu Dihua,Hung Mien-Chie^ORCID

Funder

Cancer Prevention and Research Institute of Texas

National Institutes of Health

Breast Cancer Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biochemistry (medical),Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12929-020-00670-x.pdf

Reference120 articles.

1. Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol. 2012;13(7):448–62.

2. Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA. Emerging principles for the therapeutic exploitation of glycosylation. Science. 2014;343(6166):1235681.

3. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005;5(7):526–42.

4. Jayaprakash NG, Surolia A. Role of glycosylation in nucleating protein folding and stability. Biochem J. 2017;474(14):2333–47.

5. Mereiter S, Balmana M, Campos D, Gomes J, Reis CA. Glycosylation in the era of Cancer-targeted therapy: where are we heading? Cancer Cell. 2019;36(1):6–16.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC;International Immunopharmacology;2024-10

2. Enhancing immunotherapy through PD‐L1 upregulation: the promising combination of anti‐PD‐L1 plus mTOR inhibitors;Molecular Oncology;2024-09-11

3. A functional role for glycosylated B7-H5/VISTA immune checkpoint protein in metastatic clear cell renal cell carcinoma;iScience;2024-09

4. New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

5. GFPT1 accelerates immune escape in breast cancer by modifying PD-L1 via O-glycosylation;BMC Cancer;2024-08-29